StreetAlpha.app
Home › Stocks › XRN

Chiron Real Estate Inc. (XRN)

$25.82
▼ −2.29%
LAST CLOSE · NOV 17

Chiron Real Estate is a real estate investment trust that owns healthcare properties leased to physician groups and healthcare systems. It last closed at $25.82 on Nov 17, down 2.29% on the day. The average 12-month price target from 2 analysts is $39.00 (+51.0% from the last close), with a high of $43.00 and a low of $35.00.

AI Auto Pilots
Is XRN in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$156.5M
+8.0% vs a year ago
Net income
$62.1M
+2716.7% vs a year ago
EPS (diluted)
$3.50
Valuation
Market cap
$342.1M
13.2M shares
P/E
7.4
Price over 12 month EPS
Price to sales
2.2
Market cap over revenue
Dividend yield
5.11%
$1.32 a share over 12 months
Balance sheet
Cash & equivalents
$13.5M
At Sep 30
Shareholder equity
$652.6M
Shares outstanding
13.2M
At Nov 2
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $115.9M$115.9MFY2021FY2022: $137.3M$137.3MFY2022FY2023: $141.0M$141.0MFY2023FY2024: $138.8M$138.8MFY2024FY2025: $148.2M$148.2MFY2025

From XRN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Last report
Nov 4
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated XRN in the past 90 days, not enough for a consensus
Average 12-month target
$39.00
▲ 51.0% upside

Based on 2 analysts who set a price target on XRN in the past 90 days. The average target is $39.00, with a high of $43.00 and a low of $35.00, compared with the last close of $25.82.

Low $35.00Avg $39.00High $43.00
Blue marker: last close $25.82
Highest target$43.00
Average target$39.00
Lowest target$35.00
Latest rating changes
CitizensTarget lowered
Nov 11Buy$42 → $35
Cantor FitzgeraldInitiated
Sep 21Buy$43
BMO CapitalTarget raised
Jul 13Hold$39 → $40
CitizensMaintained
May 26Buy$42
BMO CapitalMaintained
May 18Hold$39
DateFirmActionRatingPrice target
Nov 11CitizensTarget loweredBuy$42 → $35
Sep 21Cantor FitzgeraldInitiatedBuy$43
Jul 13BMO CapitalTarget raisedHold$39 → $40
May 26CitizensMaintainedBuy$42
May 18BMO CapitalMaintainedHold$39
Loading…

Technical Analysis

XRN · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 11% below its 20 day and 24% below its 50 day average. It is 35% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 28), oversold. The nearest support is the 52 week low at $25.70, and the nearest resistance the Pivot at $26.06.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 4.1%/day
Key levels
$38.6552 week high+49.7%
$34.89200 day average+35.1%
$34.47100 day average+33.5%
$32.1450 day average+24.5%
$30.27Swing high (Oct 23)+17.2%
$28.7320 day average+11.3%
$26.43Pivot R1+2.4%
$26.06Pivot+0.9%
$25.82Last close
$25.7052 week low−0.5%
$25.46Pivot S1−1.4%
Indicators
RSI (14)28.26Oversold below 30Oversold
MACD-1.64Below its signal lineBearish
Stochastic7.7Near the bottom of its rangeOversold
ADX (14)47.0Strong downtrend
Williams %R-97.8Oversold below −80, overbought above −20Oversold
CCI (20)-124.6Oversold below −100, overbought above 100Oversold
Rate of change−15.0%Change over 10 sessionsBearish
ATR (14)$1.07Typical daily range, 4.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XRN

What happened before

See how XRN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in XRN in the last 90 days.

Loading…

See today’s whale options flow across the market →

XRN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲90 buying vs 72 selling
  • ▲Held by funds +2.5 pts
  • ▲Funds holding +4
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding174170+2.4%
In funds' top 1000–
Held by funds77.7%75.2%+2.5 pts
New / increased23 / 6731 / 63−4.3%
Reduced / sold out56 / 1644 / 22+9.1%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See XRN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XRN is in one of them and how their past XRN trades turned out.

XRN in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered XRN in an article yet. Here's the latest on the wider market.

About Chiron Real Estate

Chiron Real Estate is a real estate investment trust based in Bethesda, Maryland. It owns healthcare properties and leases them to physician groups and regional and national healthcare systems. Its portfolio is mostly medical office buildings, along with inpatient rehabilitation facilities, surgical hospitals and other care sites, many located away from central hospital campuses. Most of its facilities are leased to a single tenant.

Headquarters
Bethesda, MD